Arcutis treatment helps deliver Q1 earnings beat
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Amgen shares pop 12% after excitement from obesity drug candidate
Shares of Thousand Oaks-based Amgen gained 12% on May 3, one day after the company disclosed its earnings for the first quarter of 2024 and highlighted the excitement around its weight-loss drug. During the company’s earnings call, Amgen CEO Bob Bradway commented on their obesity drug candidate, MariTide. He noted that while the company does Read More →
Sacks Parente sees signs of life in first quarter
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
American Riviera sees net income slip to start 2024
Santa Barbara-based American Riviera Bank saw net income take a slight dip in the first quarter of 2024. Announced April 24, ARB noted net income of $2.2 million for the quarter ended March 31, down from $3 million in the same quarter a year ago. According to a press release, the dip in net income Read More →
Bank of the Sierra reports higher net income in Q1
Sierra Bancorp, the parent company of Bank of the Sierra, announced its results for the first quarter of 2024 on April 23, noting that consolidated net income was at $9.3 million for the quarter, up from $8.8 million in the same quarter a year ago. According to the financial statements, the “favorable variance” in net Read More →
Analysts believe Semtech is cornering IoT market
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Atara reports higher net loss in fourth quarter
Thousand Oaks-based Atara Biotherapeutics reported financial results for the fourth quarter and full year 2023 along with recent business highlights and key upcoming milestones for 2024 on March 28. Atara reported a net loss of $60.5 million or 56 cents per share in the fourth quarter of 2023 along with a net loss of $276.1 million Read More →
